GL9:FRA
Glanbia
€ 18,35
arrow_downward
-0,05%(-0,010) 1D
6 okt, 08:05:19 GMT+2 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor GL9 genereren…
Openen
€ 18,35
Hoog
€ 18,35
Laag
€ 18,35
Beursw.
4,54 mld.
Gem. vol.
35,00
Volume
0,00
Dividend
2,43%
Kwartaaldividend
€ 0,11
Ex-dividenddatum
20 aug 2026
Koers/winst-verhouding
21,30
52 wk hoog
€ 26,00
52 wk laag
€ 13,00
WPA
€ 0,86
Aantal medewerkers
5K
Openen
€ 18,35
Hoog
€ 18,35
Laag
€ 18,35
Beursw.
4,54 mld.
Gem. vol.
35,00
Volume
0,00
Dividend
2,43%
Kwartaaldividend
€ 0,11
Ex-dividenddatum
20 aug 2026
Koers/winst-verhouding
21,30
52 wk hoog
€ 26,00
52 wk laag
€ 13,00
WPA
€ 0,86
Aantal medewerkers
5K
Nieuwsartikelen
Van webbronnen en nieuwspartners
www.marketscreener.com
·
1 dag geleden
Glanbia Kept at Buy as Berenberg Sees 'Clear Path' Toward Market Share Expansion; Price Target Up
Profiel
Glanbia plc is an Irish multinational nutrition company that owns several consumer brands that produce products such as food supplements and ingredients businesses. Glanbia is headquartered in Kilkenny, Ireland with over 5,500 employees in over 30 countries around the world. Glanbia’s consumer brands and ingredients are sold or distributed in over 130 countries.
North America is the company’s largest market, and it also has a presence in Europe, Middle East, Asia-Pacific and Latin America. Glanbia's primary listing is on Euronext Dublin. Glanbia comprises three divisions: Glanbia Nutritionals, Glanbia Performance Nutrition and Joint Ventures.
Given the company's origins in the co-operative movement, farmer-suppliers of the company retain a significant interest in the company. Tirlán remains the largest shareholder in Glanbia plc. as of 2022 and retains the right to nominate a number of non-executive directors to the board of the company in line with their mutual Relationship Agreement. Wikipedia
Over Glanbia